Goldman Sachs’s MiMedx Group MDXG Stock Holding History

Goldman Sachs’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-56,900	Closed	-$352K	–	5496
2018 Q3	$352K	Buy	56,900 +30,400	+115%	+$137K	﹤0.01%	4620
2018 Q2	$169K	Buy	+26,500	New	+$189K	﹤0.01%	5047
2018 Q1	–	Sell	-100	Closed	-$1K	–	6194
2017 Q4	$1K	Sell	100 -1,700	-94%	-$20.7K	﹤0.01%	6288
2017 Q3	$21K	Sell	1,800 -45,600	-96%	-$676K	﹤0.01%	6419
2017 Q2	$710K	Buy	+47,400	New	+$632K	﹤0.01%	4768
2016 Q4	–	Sell	-100	Closed	-$1K	–	7002
2016 Q3	$1K	Hold	100	–	–	﹤0.01%	6979
2016 Q2	$1K	Sell	100 -50,100	-100%	-$390K	﹤0.01%	6982
2016 Q1	$439K	Sell	50,200 -9,800	-16%	-$81.4K	﹤0.01%	4871
2015 Q4	$562K	Hold	60,000	–	–	﹤0.01%	4822
2015 Q3	$579K	Sell	60,000 -3,900	-6%	-$41.2K	﹤0.01%	4995
2015 Q2	$741K	Sell	63,900 -127,500	-67%	-$1.31M	﹤0.01%	4819
2015 Q1	$1.99M	Buy	+191,400	New	+$1.79M	﹤0.01%	3782

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Goldman Sachs's MDXG Position: Q1 2026 in Review

Goldman Sachs increased its MiMedx Group (MDXG) stake by 8.7% in Q1 2026, buying an estimated $479K and bringing the position to 1,185,561 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

Goldman Sachs first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $9.84M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

Goldman Sachs held 1,185,561 shares of MiMedx Group worth $4.68M as of Q1 2026.
Goldman Sachs bought 95,176 MiMedx Group shares in Q1 2026, an estimated $479K.
MiMedx Group made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3769 holding.
Goldman Sachs first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
Goldman Sachs's MiMedx Group position peaked at $9.84M in Q3 2017.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.